Pharmaceutical and health care products giant Johnson & Johnson (JNJ) posted third quarter earnings today that exceeded analyst forecasts. Profits slid to $3.2 billion, or $1.15 per share, from $3.4 billion, or $1.23 per share, in last year's third quarter.